Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
6.22
-0.18 (-2.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
Owens & Minor Revenue
Owens & Minor had revenue of $2.72B in the quarter ending September 30, 2024, with 4.99% growth. This brings the company's revenue in the last twelve months to $10.66B, up 4.22% year-over-year. In the year 2023, Owens & Minor had annual revenue of $10.33B with 3.80% growth.
Revenue (ttm)
$10.66B
Revenue Growth
+4.22%
P/S Ratio
0.04
Revenue / Employee
$480,223
Employees
22,200
Market Cap
479.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | 9.21B | -207.25M | -2.20% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
OMI News
- 3 days ago - Owens & Minor, Inc. (OMI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Owens & Minor, Inc. (OMI) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Owens & Minor, Inc. (OMI) And Encourages Shareholders to Connect - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Owens & Minor, Inc. (OMI) And Encourages Shareholders to Reach Out - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Owens & Minor, Inc. (OMI) Stockholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Owens & Minor, Inc. (OMI) and Encourages Investors to Learn More About the Investigation - Accesswire
- 10 days ago - Owens & Minor, Inc. (OMI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Owens & Minor, Inc. (OMI) And Encourages Investors to Connect - Accesswire